Cardiovascular events in patients with atherothrombotic disease: a population-based longitudinal study in Taiwan

Wen-Hsien Lee1, Po-Chao Hsu2, Chun-Yuan Chu2

  • 1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Plos One
|March 21, 2014
PubMed

Insights

This study shows that having more types of atherothrombotic disease increases the risk of adverse cardiovascular events, with ischemic stroke being more common than acute myocardial infarction in Asian populations.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Public Health

Background:

  • Atherothrombotic diseases like CVD, CAD, and PAD are leading global causes of mortality.
  • Previous studies suggested a link between polyvascular disease and poor outcomes in Asians, but lacked large-scale validation.

Purpose of the Study:

  • To validate the association between polyvascular disease and adverse cardiovascular outcomes in a large Asian population.
  • To assess the impact of an atherothrombotic disease score on subsequent cardiovascular events.

Main Methods:

  • Retrospective cohort study using Taiwan National Health Insurance Bureau data (2001-2004).
  • Included 19,954 patients diagnosed with cerebrovascular disease (CVD), coronary artery disease (CAD), or peripheral arterial disease (PAD).
  • Developed an atherothrombotic disease score based on the number of conditions; analyzed endpoints including ACS, stroke, vascular procedures, and mortality.

Main Results:

  • The event rate of ischemic stroke (18.2%) was significantly higher than acute myocardial infarction (5.7%).
  • Multivariate Cox regression revealed increased hazard ratios for ACS (1.41), all strokes (1.66), vascular procedures (1.30), and in-hospital mortality (1.14) per increment in atherothrombotic disease score (P≤0.0169).

Conclusions:

  • This large population-based study confirms that increasing atherothrombotic disease burden elevates the risk of adverse cardiovascular events.
  • The risk of subsequent ischemic stroke is notably higher than subsequent acute myocardial infarction in patients with atherothrombotic disease.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K